Clinicopathologic characteristics with different BRCA1/2 status.

For categorical data (Tumor stage and grade, residual tumor size, response to chemotherapy therapy and platinum status), the Fisher exact test was used to calculate P value in R; for continuous variable such as age, the Wilcoxon rank sum test was used in R. Patients with debulking status “no macroscopic disease” are labeled as 0 cm in residual tumor size. Number (NO.) depicts the corresponding number of patients in each category. Missing values are excluded from the test analyses. BRCA wild-type cases do not include the BRCA1 methylation cases.
Clinicopathologic characteristics with different BRCA1/2 status.

针对分类变量（包括肿瘤分期与分级、残余肿瘤体积、化疗疗效应答及铂类状态），本研究借助R软件通过费希尔精确检验（Fisher exact test）计算P值；对于年龄等连续变量，则通过威尔科克森秩和检验（Wilcoxon rank sum test）开展统计分析。肿瘤减灭状态为"无肉眼可见病灶"的患者，其残余肿瘤体积记为0 cm。例数（No.）代表各分类对应的患者数量。本次统计分析已剔除缺失值。BRCA野生型病例不包含BRCA1甲基化病例。
不同BRCA1/2状态对应的临床病理特征。